Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-24
DOI
10.1038/s41467-020-16138-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of short-term fasting on cancer treatment
- (2019) Stefanie de Groot et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study
- (2018) Stephan P. Bauersfeld et al. BMC CANCER
- Safety and feasibility of fasting in combination with platinum-based chemotherapy
- (2016) Tanya B. Dorff et al. BMC CANCER
- Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice
- (2016) Sander A Huisman et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
- (2016) Stefano Di Biase et al. CANCER CELL
- Fasting and cancer treatment in humans: A case series report
- (2016) Fernando M. Safdie et al. Aging-US
- The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
- (2015) Stefanie de Groot et al. BMC CANCER
- A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan
- (2015) Sebastian Brandhorst et al. Cell Metabolism
- Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
- (2014) A. Charehbili et al. ANNALS OF ONCOLOGY
- Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer
- (2013) B.E.P.J. Vriens et al. EUROPEAN JOURNAL OF CANCER
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
- (2012) C. Lee et al. Science Translational Medicine
- Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis
- (2012) B. C. Kahan et al. BMJ-British Medical Journal
- Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer
- (2009) T. Hickish et al. JNCI-Journal of the National Cancer Institute
- Insulin, insulin-like growth factors and neoplasia
- (2008) Michael Pollak BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Screening and referral for psychosocial distress in oncologic practice
- (2008) Marrit A. Tuinman et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy
- (2008) L. Raffaghello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started